|
68
|
250
|
4qzxA |
Ycp beta5-c63f mutant in complex with the epoxyketone inhibitor onx 0914 |
|
71
|
250
|
4qwlA |
Ycp beta5-a50v mutant in complex with carfilzomib |
|
72
|
233
|
4qv6M |
Ycp beta5-a49v mutant |
|
58
|
226
|
4r00H |
Ycp beta5-c52f mutant in complex with omuralide |
|
59
|
222
|
4qwjL |
Ycp beta5-a49t-mutant in complex with carfilzomib |
|
68
|
233
|
4qw4M |
Ycp in complex with carfilzomib |
|
72
|
233
|
4qlvM |
Ycp in complex with tripeptidic epoxyketone inhibitor 17 |
|
60
|
196
|
4qz7N |
Ycp beta5-a50v mutant in complex with the epoxyketone inhibitor onx 0914 |
|
67
|
242
|
4qw1D |
Ycp beta5-a50v mutant in complex with bortezomib |
|
73
|
240
|
4qvwC |
Ycp beta5-a49s-mutant in complex with bortezomib |
|
62
|
231
|
4qz0E |
Ycp beta5-m45v mutant in complex with the epoxyketone inhibitor onx 0914 |
|
59
|
222
|
4qwjH |
Ycp beta5-a49t-mutant in complex with carfilzomib |
|
59
|
238
|
4r3oF |
Human constitutive 20s proteasome |
|
57
|
204
|
4qwgI |
Ycp beta5-a49v mutant in complex with carfilzomib |
|
65
|
212
|
4qw3K |
Ycp beta5-c63f mutant in complex with bortezomib |
|
57
|
222
|
4qz6H |
Ycp beta5-a49t-a50v double mutant in complex with the epoxyketone inhibitor onx 0914 |
|
70
|
244
|
4qv4B |
Ycp beta5-m45t mutant |
|
60
|
222
|
4qz5L |
Ycp beta5-a49t-mutant in complex with onx 0914 |
|
68
|
244
|
4qwrB |
Ycp beta5-c52f mutant in complex with carfilzomib |
|
70
|
243
|
4qw3F |
Ycp beta5-c63f mutant in complex with bortezomib |
|
68
|
242
|
4qvpD |
Ycp beta5-m45t mutant in complex with bortezomib |
|
67
|
244
|
4qlvB |
Ycp in complex with tripeptidic epoxyketone inhibitor 17 |
|
69
|
212
|
4qwgK |
Ycp beta5-a49v mutant in complex with carfilzomib |
|
57
|
204
|
4qzxI |
Ycp beta5-c63f mutant in complex with the epoxyketone inhibitor onx 0914 |
|
73
|
212
|
4qwfK |
Ycp beta5-m45i mutant in complex with carfilzomib |
|
60
|
243
|
4r3oD |
Human constitutive 20s proteasome |
|
60
|
196
|
4qz2N |
Ycp beta5-m45i mutant in complex with the epoxyketone inhibitor onx 0914 |
|
70
|
233
|
4qvyM |
Ycp beta5-a49t-mutant in complex with bortezomib |
|
61
|
195
|
4qv1J |
Ycp beta5-m45a mutant |
|
81
|
239
|
4ramA |
Crystal structure of new delhi metallo-beta-lactamase-1 mutant m67v complexed with hydrolyzed penicillin g |
|
67
|
233
|
4qvqM |
Ycp beta5-m45i mutant in complex with bortezomib |
|
66
|
242
|
4qw4D |
Ycp in complex with carfilzomib |
|
62
|
241
|
4qz0G |
Ycp beta5-m45v mutant in complex with the epoxyketone inhibitor onx 0914 |
|
59
|
222
|
4qz1L |
Ycp beta5-m45t mutant in complex with the epoxyketone inhibitor onx 0914 |
|
56
|
204
|
4qvwI |
Ycp beta5-a49s-mutant in complex with bortezomib |
|
70
|
242
|
4qv1D |
Ycp beta5-m45a mutant |
|
56
|
204
|
4qw6I |
Ycp beta5-m45v mutant in complex with carfilzomib |
|
59
|
226
|
4qvvH |
Ycp beta5-a49v mutant in complex with bortezomib |
|
117
|
367
|
4ragA |
Crystal structure of ppc2a-d38k |
|
64
|
244
|
4qz7B |
Ycp beta5-a50v mutant in complex with the epoxyketone inhibitor onx 0914 |
|
62
|
195
|
4qwsJ |
Ycp beta5-c63f mutant in complex with carfilzomib |
|
61
|
196
|
4qv5N |
Ycp beta5-m45i mutant |
|
66
|
250
|
4r00A |
Ycp beta5-c52f mutant in complex with omuralide |
|
62
|
196
|
4qluN |
Ycp in complex with tripeptidic epoxyketone inhibitor 9 |
|
72
|
212
|
4qxjK |
Ycp beta5-m45a mutant in complex with the epoxyketone inhibitor onx 0914 |
|
72
|
240
|
4qv8C |
Ycp beta5-c52f mutant |
|
65
|
217
|
4r672 |
Human constitutive 20s proteasome in complex with carfilzomib |
|
61
|
195
|
4qz4J |
Ycp beta5-a49s mutant in complex with the epoxyketone inhibitor onx 0914 |
|
61
|
196
|
4qvyN |
Ycp beta5-a49t-mutant in complex with bortezomib |
|
66
|
233
|
4qz6M |
Ycp beta5-a49t-a50v double mutant in complex with the epoxyketone inhibitor onx 0914 |
